- Home
- FGEN vs MLSS Comparison
FGEN vs MLSS Comparison
Compare FGEN & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- MLSS
- Stock Information
- Founded
- FGEN 1993
- MLSS 1989
- Country
- FGEN United States
- MLSS United States
- Employees
- FGEN N/A
- MLSS N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- FGEN Health Care
- MLSS Health Care
- Exchange
- FGEN Nasdaq
- MLSS Nasdaq
- Market Cap
- FGEN 38.4M
- MLSS 42.4M
- IPO Year
- FGEN 2014
- MLSS 1995
- Fundamental
- Price
- FGEN $11.48
- MLSS $0.64
- Analyst Decision
- FGEN Strong Buy
- MLSS Buy
- Analyst Count
- FGEN 2
- MLSS 1
- Target Price
- FGEN $146.50
- MLSS $1.25
- AVG Volume (30 Days)
- FGEN 64.8K
- MLSS 69.7K
- Earning Date
- FGEN 08-11-2025
- MLSS 08-14-2025
- Dividend Yield
- FGEN N/A
- MLSS N/A
- EPS Growth
- FGEN N/A
- MLSS N/A
- EPS
- FGEN N/A
- MLSS N/A
- Revenue
- FGEN $7,346,000.00
- MLSS $9,083,205.00
- Revenue This Year
- FGEN N/A
- MLSS $17.24
- Revenue Next Year
- FGEN N/A
- MLSS $14.58
- P/E Ratio
- FGEN N/A
- MLSS N/A
- Revenue Growth
- FGEN N/A
- MLSS 7.84
- 52 Week Low
- FGEN $4.50
- MLSS $0.38
- 52 Week High
- FGEN $21.94
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- FGEN 59.87
- MLSS 54.99
- Support Level
- FGEN $10.65
- MLSS $0.58
- Resistance Level
- FGEN $12.60
- MLSS $0.65
- Average True Range (ATR)
- FGEN 0.82
- MLSS 0.03
- MACD
- FGEN -0.06
- MLSS 0.01
- Stochastic Oscillator
- FGEN 55.20
- MLSS 83.88
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.